A randomized clinical study comparing the analgesic efficacy of intra venous patient- controlled analgesia of morphine with fentanyl in post-operative pain management of major surgery patients
Journal Title: National Journal of Physiology, Pharmacy and Pharmacology - Year 2017, Vol 7, Issue 12
Abstract
Background: Post-operative pain is a protective but an unwanted effect which is to be treated for the better outcome of surgery. Aims and Objectives: The aim of this study is to compare the safety and analgesic efficacy of intravenous patient-controlled analgesia (IV PCA) using morphine and fentanyl for post-operative pain management in major surgery patients. Materials and Methods: The randomized clinical study initiated after the ethics committee approval and informed consenting. A total of 60 patients belonging to the American Society of Anesthesiology Grade - I, II, and III physical status, scheduled for major abdominal, oncological surgeries under general anesthesia were randomly allocated to two groups. Group M received IV PCA with morphine (basal continuous infusion 0.02 mg/kg/h, bolus dose of 0.02 mg/kg, and lockout period of 20 min), and the Group F received IV PCA with fentanyl (basal continuous infusion 0.5 µg/kg/h, bolus dose of 0.5 µg/kg, and lockout period of 20 min). Fentanyl dosage was converted into morphine equivalents. The outcomes such as visual analog scale (VAS), sedation score, hemodynamic parameters, and adverse effects were compared between groups and analyzed statistically. Results: Morphine provides better analgesia than fentanyl as indicated by lower VAS scores (score = 3) at the end of 24-72 h. Mean cumulative analgesic consumption was higher in fentanyl group (436.3 ± 330.2 mg) compared with morphine group (123.9 ± 28.2 mg) by 72 h. Regarding the hourly consumption, Group M consumed less drug than fentanyl group was statistically significant (P = 0.05). Conclusion: Morphine provides more effective post-operative analgesia than fentanyl administered through IV PCA. The PCA allows patients to balance between administration of analgesics and adverse events by self-adjusting the dose of analgesic used.
Authors and Affiliations
Brijesh Kumar, Suresha K Ramakrishnappa, Maina Bekal
Keywords
Related Articles
- EP ID EP292767
- DOI 10.5455/njppp.2018.8.1039208102017
- Views 91
- Downloads 0
Evaluation of the effect of volatile oil extract of Nigella sativa seeds on maximal electroshock-induced seizures in albino rats
Background: Epilepsy is one of the most common serious neurological disorders, responsible for substantial morbidity and mortality due to the seizures and the available medications. Natural products from folk remedies ha...
Oxidized low-density lipoprotein as an inflammatory marker in the cardiovascular disease
Background: Cardiovascular disease (CVD) is the leading cause of death in the world. Inflammation is a systemic body response aimed to decrease the toxicity of harmful agents and repair damaged tissue. Significantly, pro...
Role of serum uric acid and nitric oxide in the diagnosis of Type 2 diabetes mellitus - A case–control study
Background: The studies have reported that high serum uric acid (UA) and low nitric oxide (NO) levels are strongly associated with prevalent health conditions such as obesity, insulin resistance, metabolic syndrome, diab...
Correlation of pain sensitivity and sweet taste in healthy male adults
Background: Many studies have established a relationship between the administration of small amounts of sweet - tasting (sucrose) solution to the tongue and analgesia in rat pups and human infants. Hence, we inten...
Anti inflammatory property of salbutamol on acute and chronic models of inflammation
Background: β2-Adrenergic receptor agonist agents were able to suppress the immune response by inhibiting release of IL-12 and production of TNF-α by the direct stimulation of β-adrenergic receptors on inflammator...